I think there's a study out there that shows that while brand name drugs are about 10 percent of all drugs that are dispensed, I think that's including biologics in the equation, they make up about 72 percent of the annual U.S. drug spending.
Sarbanes highlights the financial impact of brand name drugs on U.S. drug spending.
Share
More from John Sarbanes
It's a national environmental treasure. It's a regional economic engine. It's been one of my top priorities since I've come to Congress.
But these are dramatic changes that can bring us to a new place and, I think, have given many people a sense of hope instead of despair in the face of what we are seeing with a warming planet.
They want to be on the field of their democracy. They want to feel like they have some power within their own democracy.
I hope that today's hearing is the first step in continuing that legacy of strong bipartisan support for the Chesapeake Bay in this Congress.
Other voices in this conversation
